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The mechanisms by which the excess genetic material of chromosome 21 results in the dysmorphologic features of Down syndrome
(DS) are largely unknown. It has been found that the extracellular matrix of nuchal skin of DS fetuses exhibits an higher content of
hyaluronan (HA) compared to that of euploid fetuses. Since HA plays a central role in many morphogenetic processes during
embryogenesis, an alteration in its metabolism could be involved in the pathogenesis of several structural defects of DS. The extracellular
matrix of umbilical cord (UC) is the mammalian tissue with one of the highest content of HA. Therefore we sought to explore the
quantitative HA modifications during gestation, tissue distribution and HA metabolism in euploid and DS UCs. Euploid UCs (n =28) and
UCs from DS fetuses (n =13) were obtained after termination of pregnancy, spontaneous abortion, or at delivery. Quantitative and
molecular size analysis were performed using HPLC and FPLC. Tissue distribution was visualized by immunohistochemistry. Gene
expression for HA synthases (HAS) and hyaluronidases (HYAL) were quantified by real-time PCR techniques and HYAL activity was
detected by zymography. In euploid UC only HA of a molecular weight of 1700 kDA was present while in DS UC an additional lower
weight HA molecule of 1100 kDA was found. Immunohistochemistry showed a larger amount of Wharton’s jelly HA in DS UCs than in
euploid UC. Real-time PCR analysis showed that HAS 2 and HYAL 2 were expressed at significant levels in all specimens. A higher
expression of HAS 2 and a lower expression of HYAL 2 was found in the Wharton’s jelly of DS fetuses compared to that of euploid
fetuses at 14 weeks of gestation. On the contrary, at term HYAL 2 expression was higher in DS specimens than in those from euploid
fetuses. Zymographic studies showed a similar behavior with a lower HYAL activity at early gestation and a higher HYAL activity at term
gestation in DS UCs compared to euploid specimens. Therefore we can conclude that HA is more represented in DS UCs than in euploid
UCs. A complex alteration of the HA metabolism characterized by an increased synthesis of lower weight HA molecules is a peculiarity
of DS UCs.
D 2005 Elsevier B.V./International Society of Matrix Biology. All rights reserved.Keywords: Umbilical cord; Down syndrome; Hyaluronan; Hyaluronidase; Hyaluronan synthase1. Introduction
HA is a component of the connective tissue and is
present in the extracellular matrix (ECM) of most vertebrate
tissues (Laurent, 1998). In some cases HA is a major0945-053X/$ - see front matter D 2005 Elsevier B.V./International Society of Ma
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E-mail address: luigi.raio@insel.ch (L. Raio).constituent as, for example, in the vitreous of the human eye
(0.1–0.4 mg/g wet weight) (Meyer and Palmer, 1934), or in
the matrix produced by the cumulus cells around the oocyte
prior to ovulation (¨0.5 mg/ml). (Salustri et al., 1990). In
other tissues, such as cartilage (Knudson and Knudson,
2001), even representing less of the mass of the tissue, HA
serves as an essential structural element in the matrix. In the
past decade a growing body of evidence has shown that HA,
previously thought of as an inert space-filling component of005) 166 – 174trix Biology. All rights reserved.
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Fig. 1. Correlation between gestational age and HA content in umbilical
cords of euploid fetuses [Spearman Rank Correlation: r =0.80, p <0.001
(95% CI: 0.90;0.60)]. Data are expressed as pmoles of unsaturated
disaccharides derivatized with AMAC in 1 mg of dry tissue.
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Fig. 2. Hyaluronan content in euploid and trisomy 21 umbilical cords
between 14 and 21 weeks of gestation. Data are expressed as pmoles of
unsaturated disaccharides derivatized with AMAC in 1 mg of dry tissue.
L. Raio et al. / Matrix Biology 24 (2005) 166–174 167ECM, plays a central role in many morphogenetic processes
during vertebrate embryogenesis.
Down syndrome represents a condition of inborn errors
of morphogenesis that results from an extra copy of
chromosome 21. The mechanisms by which the excess
genetic material of chromosome 21 results in the dysmor-
phology of Down syndrome have not been defined. Several
studies showed that alterations of the ECM, with a
substantial increase in HA concentration, could be the
underlying cause for the increased nuchal translucency
frequently present in trisomy 21 fetuses at early gestational
age (Von Kaisenberg et al., 2003; Bohlandt et al., 2000; Von
Kaisenberg et al., 1998a; Brand-Saberi et al., 1994a,b).
Moreover, the composition of the ECM seems critical for
the development of heart defects involving endocardial
cushion differentiation, in particular the atrioventricular
canal, which accounts for nearly half of the congenital heart
diseases observed in Down syndrome subjects (Eisenberg
and Markwald, 1995).
The matrix of the umbilical cord is considered to be the
mammalian tissue with one of the highest content of HA
(¨4 mg/ml) (Weissman and Meyer, 1954). Recently, it has
been reported that the umbilical cord morphology of Down
syndrome fetuses is different than that of healthy fetuses
(Raio et al., 2004; Moessinger et al., 1986). In particular, it
has been noted that trisomy 21 fetuses seem to have
shorter umbilical cord as well as a lower number of coils
than healthy fetuses (Raio et al., 2004; Moessinger et al.,
1986). The histological and biochemical basis of these
findings are largely unknown. The composition of ECM of
umbilical cords in Down syndrome fetuses has been poorly
investigated to date. We performed this study to explore
the content, distribution pattern, and molecular size of
hyaluronan in ECM of umbilical cords of euploid and
Down syndrome fetuses. Moreover, the expression of
genes encoding hyaluronan synthases (HAS) and hyalur-
onidases (HYAL) in umbilical cord ECM has been
evaluated.2. Results
The umbilical cord content of HA has been analysed
measuring HA disaccharides by HPLC after specific
enzymatic digestions (see Experimental procedure section
for details). In euploid fetuses the umbilical cord HA
amount decreased significantly with advancing gestation
(Fig. 1). Similarly, an inverse significant correlation was
found between HA concentration and gestational age in
Down syndrome cases [r=0.75, p=0.003 (95% CI:
0.92; 0.34)]. Considering only specimens between 14
and 21 weeks of gestation (since most trisomy 21 UCs
were achieved from terminations of pregnancy at this
gestational age), an higher HA content was found in
trisomy 21 fetuses (n=10) compared with healthy fetuses
(n=7) [44840 (26010–71460) vs. 24370 (7729–47110)
disaccharide pmol/mg dry tissue; p =0.009] (Fig. 2). A
gestational age-matched (T4 days) healthy control was
available for 9 trisomy 21 fetuses. The umbilical cord HA
content was higher in trisomy 21 fetuses than in healthy
fetuses in 8 pairs (Fig. 3). The median difference in
umbilical cord HA content between pairs was 9113 pmol/
mg dry tissue (range: 16491–63728).
Immunohistochemistry of HA based on biotinylated
HA binding protein (bHABP) decoration showed a
different distribution pattern in umbilical cords from
trisomy 21 fetuses compared to the control group (Fig.
4). As expected from biochemical analysis, Wharton’s
jelly of trisomic cords was intensely stained, showing a
large amount of HA with homogeneous distribution,
whereas euploid umbilical cord specimens were much
less positive for HA. On the contrary, the intensity of HA
decoration observed in smooth muscle cells of umbilical
cord vessels was much higher in euploid than in trisomy
21 umbilical cords. This HA distribution pattern did not
change comparing umbilical cord specimens at early and
late gestational age both in normal and trisomy 21
fetuses.
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Fig. 3. Hyaluronan content in trisomy 21 and euploid umbilical cords matched for gestational age (T4 days). A suitable control was not available for the last
four cases of Down syndrome umbilical cords. (>control; ? trisomy21). In parentheses is reported the gestational age, weeks+days.
L. Raio et al. / Matrix Biology 24 (2005) 166–174168Structural studies on the HA molecular size were carried
out using a FPLC analysis, in order to separate intact mature
HA molecule from its degradation fragments (oligosacchar-
ides) (Fig. 5). Chromatographic data showed that the
umbilical cord extracellular matrix of euploid fetuses at 14
weeks of gestation contains large HA molecules (about 1700
kDA), included in a single peak, and the retained fraction
further analysed by FACE (Fig. 5, panel A). Conversely, in
trisomy 21 specimens of the same gestational age, FPLCA                                                    B
V
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Fig. 4. Immunohistochemical staining for hyaluronan with biotin-labeled HA Bind
weeks+4 days; (B) trisomy 21 umbilical cord at 14 weeks+0 days (stained addi
euploid umbilical cord at 37 weeks+4 days; (D) trisomy 21 umbilical cord at 37analysis splitted mature HA in two chromatographic peaks
(Fig. 5, panel B). In addition to the 1700 kDa fraction, a
population of HA with lower molecular weight (1100 kDA)
has been observed. To check peak composition, analysis of
the eluted material in the peaks was carried out with
electrophoresis (FACE), analysing unsaturated disaccharides
obtained after specific enzymatic treatment of the material
eluted from the column and AMAC derivatization. These
data showed that peaks eluted in void volume of the columnJ
V
V
J
ing Protein (bHABP). Magnification 100. (A) euploid umbilical cord at 13
tionally with DAPI to identify carefully the smooth muscle cells area); (C)
weeks+3 days. V, umbilical cord vessel; J, Wharton’s jelly.
L. Raio et al. / Matrix Biology 24 (2005) 166–174 169(i.e. both peaks of 1700 and 1100 kDa) contain only HA,
while all the other retained fractions contained sulphated
oligosaccharides.
Real-time PCR experiments showed that only HAS 2 and
HYAL 2 were expressed at significant levels in umbilical
cords of either trisomy 21 and euploid fetuses, irrespective of
gestational age, whereas HAS 1, HAS 3 and HYAL 1 were
almost undetectable. Fig. 6 displays HAS 2 and HYAL 2
gene expression in umbilical cords obtained from two Down
syndrome and two euploid fetuses at 14 weeks of gestation
and at term. mRNA from Wharton’s jelly and umbilical
vessels was extracted separately only in term specimens.
Indeed, in 14 weeks samples, the vessels portion was
contaminated by Wharton’s jelly tissue, and therefore we
were able to purify only Wharton’s jelly mRNA. In Down
syndrome specimens HAS 2 expression in the Wharton’s
jelly was higher than in euploid specimens, irrespective of
gestational age (Fig. 6, panel 1). Opposite findings were
evident in umbilical vessels fraction in specimens at term
(Fig. 6, panel 2). Interestingly, in Wharton’s jelly of euploid
specimens the HAS 2 expression decreases during preg-
nancy, whereas in Down syndrome UCs the expression ofFig. 5. Gel filtration chromatography of glycosaminoglycans extracted from
human umbilical cords at 14 weeks of gestation. (A) material from euploid
fetuses. (B) material from trisomy 21 specimens. The arrows indicate the
calculated molecular mass of HA containing peaks.HAS 2 showed an opposite trend (Fig. 6, panel 1). At 14
weeks of gestation, Wharton’s jelly from euploid specimens
showed an higher HYAL 2 expression than that in trisomy
21, whereas the trend is opposite at term of gestation (Fig. 6,
panel 3). Similarly to HAS 2 data, in euploid tissues the
HYAL 2 expression decreases from 14 weeks to term,
whereas in Down syndrome tissues the trend is opposite (Fig.
6, panel 3). HYAL 2 expression in the umbilical vessels is
much higher in trisomy 21 specimens than in normal tissue at
term (Fig. 6, panel 4).
In Fig. 7 are shown the HYAL activities in samples
from umbilical cords at 14 weeks and term using gel
zymography. In gel zymography experiments, samples
matching for gestational age and containing the same
amount of protein were compared, in the range of 10 to 50
Ag. Gels were developed in buffers either at pH 3.5 or 5,
but only in pH 3.5 was the HYAL activity detectable. Two
bands were mainly detected in all samples with molecular
masses of 80 and 67 kDa. In addition, Down syndrome
specimen at term gestation presented a third band of 51
kDa. The molecular mass of the bands were measured
using a mix of standard proteins running in the same gel.
As expected from real-time PCR experiments, zymography
confirmed that in the 14 weeks specimen the HYAL
activity was more evident in euploid than in Down
syndrome tissues (Fig. 7, lane 2 and 3 respectively),
whereas at term the enzymatic activity is more detectable
in Down syndrome samples in comparison to healthy
specimen (Fig. 7, lane 4 and 5).3. Discussion
The present study clearly demonstrates that umbilical
cords of Down syndrome fetuses have a higher HA
amount than euploid fetuses and a peculiar distribution
pattern of this glycosaminoglycan. This finding is con-
sistent with previous immunohistochemistry investigations
on nuchal skin of trisomy 21 fetuses at term (Von
Kaisenberg et al., 2003; Bohlandt et al., 2000; Von
Kaisenberg et al., 1998a; Brand-Saberi et al., 1994a,b).
An interesting finding of the present study is the
progressive decrease with gestational age of HA content
found in both normal and Down syndrome umbilical
cords. Quantitative changes in ECM composition and in
particular in HA amount might be an explanation for the
dynamic course of the nuchal translucency thickness with
advancing gestational age. Longitudinal studies performed
on weekly measurements by sonography of nuchal trans-
lucency (both in trisomy 21 and in euploid fetuses) have
shown that in most cases nuchal translucency is a
transient phenomenon (Pajkrt et al., 1998; Zoppi et al.,
2003). If the cause of the nuchal translucency enlarge-
ment is the swelling of interstitial spaces due to the
hydrophilic properties of HA, it is reasonable to
hypothesize that a decreasing amount of this polysacchar-
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Fig. 6. Gene expression analysis by real-time PCR for hyaluronan synthases 2 (HAS 2) (panels 1 and 2) and hyaluronidases 2 (HYAL 2) (panels 3 and 4); black
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resolution of the enlargement.
The identification of genes encoding for HASs and
HYALs and studies of animal and human genetics have
widely contributed to the recent understanding of the role
played by HA during embryogenesis. Three major physio-
logical functions of this molecule seem to be crucial for120
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Fig. 7. Hyaluronidase activity by SDS-PAGE zymography using HA-
copolymerized gel, developed at pH 3.5 and stained with 0.5% Alcian blue.
Lane 1, positive control (sample from the medium of BC8701 cell line
culture); lane 2 and 3, umbilical cord samples of euploid and Down
syndrome fetuses at 14 weeks of gestation; lane 4 and 5, umbilical cord
samples of euploid and Down syndrome fetuses at term gestation,
respectively.normal development: first, HA, due to its peculiar biophysical
properties, greatly influences tissue homeostasis and bio-
mechanics; second, the interactions with other components of
ECM is essential for the structural integrity of several tissues;
third, HA interacts with cell surface receptors influencing cell
signaling and function. Particularly, a mechanism by which
HA controls cell behavior is the creation of pericellular
‘‘coats’’, a hydrated pericellular zone that facilitates mitosis
and cell migration through the extracellular matrix (Toole,
2001; McDonald and Camenisch, 2002). Studies on HA
deficient mouse embryos clearly illustrate the importance of
each of these functions in morphogenesis (Spicer et al.,
2002). Since HA is an ubiquitous glycosaminoglycan, it is
reasonable to speculate that an altered composition of ECM
in trisomy 21 fetuses may not merely account for the
increased nuchal translucency or umbilical cord abnormal-
ities, but could also be involved in the pathogenesis of other
clinical features encountered in this chromosomal disease. A
high concentration of HA has been shown to impair the
migration of neural crest cells, leading to enteric nervous
system anomalies (i.e. Hirschsprung’s disease, frequently
associated with trisomy 21) (Payette et al., 1988) and
affecting other organs receiving cell contribution from the
neural crest (Kirby et al., 1983). Moreover, studies on HAS
2/ mice embryos (lacking functional HAS 2 genes)
clearly point to the importance of HA in expansion of the
L. Raio et al. / Matrix Biology 24 (2005) 166–174 171cardiac cushion matrix and demonstrate that this molecule is
required for endothelial cell transformation to mesenchymal
cells and their migration into cardiac jelly (Camenisch et al.,
2000). Alteration in HA metabolism associated with Down
syndrome may therefore be responsible for a specific defect
in heart septation, such as the atrioventricular canal (Eisen-
berg and Markwald, 1995; Camenisch et al., 2000). Possible
mechanisms leading to increased content of HA in the
extracellular matrix of trisomy 21 fetuses remains to be
explored. Overexpression of genes located on chromosome
21 and indirectly involved in HA metabolism (alpha 1 and 2
chain of collagen type VI (Von Kaisenberg et al., 1998b),
and the enzyme superoxide-dismutase—SOD (Turrens,
2001)) has been advocated as a possible explanation of
the increased HA amount. However, these speculations have
never been unequivocally tested and evidences from animal
models do not support these possible explanations (Von
Kaisenberg et al., 1998a).
The HYAL activity, using zymography, has been
widely studied in different cell lines and tissues. In a
recent work (Fiszer-Szafarz et al., 2000) it was demon-
strated that in human serum and placenta, native HYAL is
present and active at pH 3.5 with the most active form of
67 kDa. In our study, HYAL activity was observed at pH
3.5. Two or three different bands were observed which
may present different forms of HYAL, with the most
active of 67 kDa.
Although the results of the present study are not
conclusive, the mRNA results on HAS are supported by
HA content in the samples and the findings on HYAL 2
have been confirmed measuring the enzymatic activity by
zymography. Therefore, the different HAS 2 and HYAL 2
gene expression in Wharton’s jelly and umbilical vessels
tissues in euploid and Down syndrome UCs is remarkable.
Moreover, these findings are in agreement with the different
HA amount showed by immunohistochemistry. This sug-
gests that the extracellular matrix of these tissues undergo a
diverse regulation of the HA metabolism. The presence of a
family of HAwith a smaller size in trisomy 21 specimens, as
reported by chromatographic analysis, can be explained by
the striking imbalance between HAS 2 and HYAL 2
expression, mainly in early gestation.
Cumulatively, our findings imply that the Down
syndrome umbilical cord extracellular matrix is affected
by a complex alteration of HA metabolism, involving not
only its amount, distribution and structure but also cell
metabolism. This is particularly true as the umbilical
cord’s lack of lymphatic network and therefore differ-
ences in lymphatic clearance of these polysaccharides
may not account for the observed differences in HA
content between normal and Down syndrome umbilical
cords. Further studies on cell cultures are needed to
clarify the HA metabolism in human umbilical cord and
the role played by this molecule in the pathogenesis of
the different phenotypic features of Down syndrome
fetuses.4. Experimental procedure
4.1. Study population
Between June 2002 and December 2003, 28 and 13
umbilical cord segments were obtained from euploid and
trisomy 21 fetuses, respectively. The karyotype was obtained
at chorionic villous sampling, at amniocentesis, from
spontaneous abortion tissue or from peripheral neonatal
blood. The umbilical cords were collected either after
termination of pregnancy, after spontaneous abortion or at
delivery. Gestational age was calculated on a reliable
recollection of the last menstrual period and confirmed at
first trimester ultrasound.
The umbilical cords were processed only if the following
conditions were met: 1) known gestational age, 2) singleton
gestation, 3) absence of structural malformations in the
control population, 4) no histological evidence of funisitis,
and 5) three vessel umbilical cord. Medical complications of
pregnancy (e.i., preeclampsia, diabetes) were considered
exclusion criteria. Immediately after abortion or delivery 1–3
cm portions of the umbilical cord were frozen at80 -C and
sent to the biochemistry laboratory. The presence of a viable
fetus at the time of termination of pregnancy or abortion was a
prerequisite for processing the umbilical cord segments.
Written informed consent was obtained from all participants
to the study. The study was approved by the Institutional
Review Board.
4.2. Reagents used for biochemical analysis
Proteinase K came from Finnzyme (Epoo, Finland).
Hyaluronidase SD and Chondroitinase ABC were purchased
from Seikagaku (Tokyo, Japan), biotinylated HABP was
kindly provided by Akira Asari of Seikagaku (Tokyo, Japan).
Standard disaccharides were obtained from Sigma (St. Louis,
MO, USA), 2-aminoacridone (AMAC) came fromMolecular
probes (Eugene, OR, USA). FITC-streptavidin was pur-
chased from Vector (Burlingame, CA, USA) and Texas red
secondary antibody came from Santa-Cruz Biotechnology
(Santa Cruz, CA, USA). Water used for aqueous solutions
was of MilliQi. All other chemicals were of analytical
reagent grade.
4.3. Isolation and degradation of HA
Frozen samples of human umbilical cords were lyophi-
lized, suspended in 300 Al of 0.1 M ammonium-acetate pH
7, and digested with protease K at 60 -C for 2 h. After
enzyme inactivation, 1.2 ml ethanol 96% (or absolute
ethanol) was added and the mixture was frozen at 20 -C
overnight to precipitate the glycosaminoglycans. After
centrifugation at 10,000g at 4 -C for 15 min, the pellets
were solubilized with 100 Al of 0.1 M ammonium-acetate
pH 7 and sonicated for 1 min in a ultrasound bath.
Polysaccharides were digested with 100 mU/ml hyalur-
L. Raio et al. / Matrix Biology 24 (2005) 166–174172onidase SD at 37 -C for 1 h and then with 100 mU/ml
Chondroitinase ABC at 37 -C for 3 h. The samples were
lyophilized and derivatized with AMAC, according to a
previous study (Calabro et al., 2000).
4.4. HPLC analysis
Separation and analysis of derivatized products were
performed with a Jasco–Borwin chromatograph system with
a fluorophore detector (Jasco FP-920, kex=442 nm and
kem=520 nm). Chromatography was carried out using a
reversed phase column (C-18, 4.6150 mm, Bischoff,
Germany) at room temperature, equilibrated with 0.1 M-
ammonium acetate, pH 7.0, filtered through a 0.45 Am
membrane filter. A gradient elution was performed using a
binary solvent system composed of 0.1M-ammonium acetate
pH 7.0 (eluent A), and acetonitrile (eluent B). The flow rate
was 1ml/min and the following programwas used: pre-run of
column with 100% eluent A for 20 min, isocratic elution with
100% eluent A for 10 min and gradient elution to 30% eluent
B for 30 min. Sample peaks were identified and quantified
comparing the fluorescence spectra with standard unsaturated
disaccharides, using a Jasco–Borwin software.
4.5. FPLC analysis of HA molecular size
Separation and analysis of HA after derivatization with
AMAC was performed using Fast Protein Liquid Chroma-
tography (FPLC) (AKTA Amersham Pharmacia Biotech,
Uppsala, Sweden). Gel chromatography was carried out
using a Superdexi 200HR 10/30 prepacked column (10mm
internal diameter, 30–31 cm height of the packed bed,
Amersham Pharmacia Biotech, Uppsala, Sweden) at room
temperature. The buffer used was 0.1 M ammonium acetate,
pH 7.0, with 0.05% Tween-20, and the flow rate was 0.35 ml/
min. Sample peaks were identified and quantified comparing
the absorbance at 280 nm with standard HA proteins. The
identification and quantification of polysaccharides was
performed after fraction collection (2 ml each) and digestion
with hyaluronidase SD and chondroitinase ABC were as
described above. The obtained unsaturated disaccharides
were derivatized with AMAC and analysed by FACE
(Karousou et al., 2004).
4.6. HA staining with biotin-labeled HA-binding protein
(bHABP)
Specimen of fixed human umbilical cords from control
and trisomy 21 fetuses were prepared for bHABP staining on
superfrost slides of 5 Am thickness. bHABP recognizes HA
saccharidic sequences and is able to localize HA in tissues.
The blocking procedure was carried out using 3% fetal
bovine serum (FBS) in PBS buffer for 1 h at room
temperature. The bHABP was diluted in 3% FBS in PBS to
10 Ag/ml and incubated in a humidified chamber at 4 -C
overnight. After washing procedure in PBS, the bHABP wasevidentiated with streptavidin conjugate with FITC and
visualized using a microscope (Leica, Germany) equipped
with an appropriate filter and a digital camera. Control
experiments were carried out by incubating the slides with
bHABP after digestion with hyaluronidase from Streptomy-
ces at 37 -C for 2 h.
4.7. RNA extraction and cDNA synthesis
Studies were performed on Wharton’s jelly and vessels
taken separately only from two umbilical cords of euploid
fetuses and two Down syndrome fetuses at term of
gestation. Wharton’s jelly of each umbilical cord was
carefully separated from vessels using microsurgery tools
and a stereomicroscope. In the specimens of 14th weeks of
gestation only the Wharton’s jelly was purified for mRNA
study. Total mRNA from each sample was isolated using
the RNAqueus-4PCR kit from Ambion (Cambridgeshare,
UK), followed by a DNase treatment, included in the kit.
The concentration of purified RNA was determined
fluorometrically using the RiboGreen\ RNA Quantitation
Reagent and Kit from Molecular Probes (Leiden, the
Netherlands). Equal amounts (80 ng) of total RNA from
each tissue samples were reverse transcribed using random
primers (hexamers), according to the protocol of High
Capacity cDNA Archive Kit from Applied Biosystems
(Foster City, CA). A RNase inhibitor (Applied Biosystems,
Foster City, CA) at final concentration of 1.0 U/ml, was
also included in the reaction.
4.8. Real-time PCR
Real-time PCR was performed by means of TaqMan
technology and ABI Prism 7700 apparatus (Applied
Biosystems, CA, USA). All mammalian HASs (HAS1,
HAS2 and HAS3) and the more common mammalian
HYALs (HYAL 1 and 2) gene expression were studied.
RNase P was used as a housekeeping gene. For these
experiments, oligonucleotide primers and TaqMan\ probes
were Assays-on-Demand of Applied Biosystems. PCR
reaction mix contained 2.5 Al of cDNA, 12.5 Al of Universal
Master Mix (Applied Biosystems), 1.25 Al of Assay-on-
Demand primer and probe and 8.75 Al of nuclease-free
water. The PCR program consisted of an initial hot start at
50 -C for 2 min, followed by 95 -C for 10 min and 45
amplification cycles (95 -C for 15 s and 60 -C for 60 s).
For each sample, ABI PRISM 7000 Sequence Detection
System (SDS) software plotted an amplification curve by
relating the fluorescence signal intensity (DRn) to the cycle
number. A relative quantitative analysis was performed,
using the 2$(DDCt) value, where DCt=Ct (target)Ct
(endogenous control) and DDCt=DCt (sample)DCt (cal-
ibrator) (being Ct=number of cycle of exponential fluo-
rescence beginning). RNase P was used as an endogenous
control and the sample with the lower expression of the
target was used as calibrator.
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A 200–300 mg wet-weight piece of umbilical cords of
euploid and Down syndrome fetuses at term gestation were
homogenised in 1 ml of PBS containing 0.1% Triton X-100
with the ULTRA-TURRAX\. After centrifugation (15 min at
4 -C), the supernatants were kept in 20 -C until any
experimental procedure. Total protein quantification was
performed by Bradford method using 3 Al of volume of each
sample.
The hyaluronidase activity was detected by zymography,
as described before by Miura et al., 1995. Briefly, an
electrophoresis run was performed in 8% SDS acrylamide
gel (1-mm thickness) containing 170 Ag/ml of umbilical cord
HA (final concentration). After the electrophoretic run and
2,5% Triton X-100 incubation, gels were incubated overnight
at 37 -C in 0.1 M sodium formate, 0.15 M NaCl, pH 3.5
buffer, or in 50 mM citric acid-Na2HPO4, 0.15 M NaCl, pH
5.0 buffer. Finally, gels were stained in 0.5% Alcian blue.
HAase activity was detected as unstained bands correspond-
ing to the migrated positions of the enzymes. The medium of
cell culture of the BC8701 cell line was used as positive
control and a commercial mix of proteins (BIO-RAD,
Hercules, CA).
4.10. Statistical analysis
Statistical analysis was performed with GraphPad Prism
version 3.00 for Windows, (GraphPad Software, San
Diego CA). To allow a meaningful comparison of the
umbilical cord HA content, for each trisomy 21 specimen a
gestational age-matched healthy specimen (T4 days) was
looked for. Statistical significance was considered achieved
when P was less than 0.05.Acknowledgments
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